Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Palmitoleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 known ✓ | P0DMS8 | 1/20 | 0.66 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.66 |
| ▸ | PPARG known ✓ | P37231 | 1/20 | 0.66 |
| ▸ | FABP3 | P05413 | 9/20 | 0.96 |
| ▸ | TERT | O14746 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 2/20 | 0.66 |
| ▸ | BLM | P54132 | 2/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.66 |
| ▸ | FABP4 | P15090 | 2/20 | 0.66 |
| ▸ | GMNN | O75496 | 1/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | APEX1 | P27695 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | RECQL | P46063 | 1/20 | 0.66 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9356018 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Oleic Acid SCHEMBL873180 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Oleic Acid SCHEMBL3803217 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Vaccenic Acid SCHEMBL9356059 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| SCHEMBL25399853 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Vaccenic Acid SCHEMBL9359850 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| SCHEMBL25400903 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Nervonic Acid SCHEMBL25231555 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Palmitoleic Acid SCHEMBL25179789 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 | |
| Palmitoleic Acid SCHEMBL141874 | 1.00 | FABP3 (0.96) | FABP3TERTMAPTBLMHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 477 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080243-A | Saccharide supermolecule emulsifier and preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122011409-A | Chitin supermolecule emulsifier and its preparation method and application | 优姿康生物科技(无锡)有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-122011407-A | Supermolecule hyaluronic acid emulsifier and preparation method and application thereof | 优姿康生物科技(无锡)有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260022309-A1 | COMPOSITIONS AND METHODS OF USE FOR EQUIPMENT DEGREASING | ECOLAB USA INC (US) | 2026-01-22 | — | — | US | claimed |
| EP-4569061-A1 | COMPOSITIONS AND METHODS OF USE FOR EQUIPMENT DEGREASING | Ecolab USA, Inc. (US) | 2025-06-18 | — | — | EP | claimed |
| WO-2025102718-A1 | METHOD FOR PREPARING POLYMER, POLYMER AND USE, SEPARATOR, BATTERY, AND ELECTRICAL DEVICE | 宁德时代新能源科技股份有限公司 | 2025-05-22 | — | — | WO | claimed |
| CN-119978214-A | Polymer preparation method, polymer and application, separator, battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| WO-2025093572-A1 | SOLID DISPERSION COMPOSITIONS AND USES THEREOF | TRx Biosciences Limited (GB) | 2025-05-08 | — | — | WO | claimed |
| CN-119585407-A | Compositions for degreasing devices and methods of use | 埃科莱布美国股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| EP-4493151-A2 | COMPOSITIONS HAVING IMPROVED BIOAVAILABILITY OF THERAPEUTICS AND USES THEREOF | TRX Biosciences Limited (GB) | 2025-01-22 | — | — | EP | claimed |
| CN-110857422-A | Preparation method of Chinese herbal medicine antibacterial soap | 向杰 | 2020-03-03 | — | — | CN | claimed |
| CN-110857423-A | Chinese herbal medicine antibacterial soap | 向杰 | 2020-03-03 | — | — | CN | claimed |
| WO-2016126930-A1 | EMULSION CONTAINING TWO OILS AND STABILIZERS | NANOMEDEX, LLC (US) | 2016-08-11 | — | — | WO | claimed |
| US-20160228384-A1 | EMULSION CONTAINING TWO OILS AND STABILIZERS | NANOMEDEX, LLC | 2016-08-11 | — | — | US | claimed |
| WO-2014128564-A2 | PHARMACEUTICAL COMPOSITIONS OF CETP INHIBITORS | DR. REDDY'S LABORATORIES LTD. (IN) | 2014-08-28 | — | — | WO | claimed |
| US-7137975-B2 | Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent | ACIONT, INC. (US) | 2006-11-21 | — | — | US | claimed |
| EP-1556001-A2 | THERAPEUTIC COMPOSITIONS FOR DRUG DELIVERY TO AND THROUGH COVERING EPITHELIA | UMD, Inc. (US) | 2005-07-27 | — | — | EP | claimed |
| US-20040151774-A1 | Therapeutic compositions for drug delivery to and through covering epithelia | UMD, INC. | 2004-08-05 | — | — | US | claimed |
| WO-2004041118-A2 | THERAPEUTIC COMPOSITIONS FOR DRUG DELIVERY TO AND THROUGH COVERING EPITHELIA | UMD, INC. (US) | 2004-05-21 | — | — | WO | claimed |
| US-20020161323-A1 | Method for increasing the battery life of an alternating current iontophoresis device using a barrier-modifying agent | ACIONT INC. | 2002-10-31 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022309-A1 | COMPOSITIONS AND METHODS OF USE FOR EQUIPMENT DEGREASING | SI, SMARCC2, SMARCC1 | ADORA3 512/4885PTGS1 1613/4885PPARG 1326/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.